STARD13-AS

Across TCGA pan-cancer cohorts, STARD13-AS RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of STARD13-AS’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where STARD13-AS RNA is repressed in tumor relative to normal tissue. In most cancer types STARD13-AS is over-expressed in tumor, although a few such as THCA and KIRP show the opposite, repressed pattern.

THCA, KIRP, and LUSC are the cancer types where STARD13-AS tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in STARD13-AS RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Female	II,III,IV	−0.473	<.001	11	view →
KIRP	All	All	−0.378	<.001	9	view →
LUSC	Female	All	−0.442	<.001	7	view →
LUAD	All	III,IV	−0.408	<.001	6	view →
KICH	All	All	−0.510	<.001	5	view →
READ	All	All	−0.164	<.001	5	view →
KIRC	Male	All	−0.205	<.001	4	view →
UCEC	All	All	−0.158	<.001	4	view →
BRCA	All	III,IV	−0.395	<.001	2	view →
CHOL	All	II,III,IV	+0.125	.026	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

STARD13-AS–THCA

Open the THCA breakdown →